Invitrogen™ Kit ELISA of human beta-2 microglobulin (B2M)
Ref.: BL-RE-091966Manufacturer ref.: EHB2MX10 10 x 96 tests
€4,815.00 excl. VAT
Beta-2-microglobulin (B2M) is a 12-14 kDa protein, a subunit of the main class I histocompatibility complex (MHC). The human beta 2-microglobulin associated with HLA Class I antigens is expressed on many types of human...
Accession number
P61769
Dose range
15.6 to 1000 pg/ml
Sensitivity of the dosage
6 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Beta-2-microglobulin (B2M) is a 12-14 kDa protein, a subunit of the main class I histocompatibility complex (MHC). The human beta 2-microglobulin associated with HLA Class I antigens is expressed on many types of human...
Beta-2-microglobulin (B2M) is a 12-14 kDa protein, a subunit of the main class I histocompatibility complex (MHC). Human beta 2-microglobulin associated with HLA Class I antigens is expressed in many cell types, including lymphocytes, thymocytes, monocytes, granulocytes, platelets, endothelial cells and epithelial cells, but is absent from erythrocytes. Beta-2 microglobulin also exists in free form in plasma. The amino acid sequence of beta-2-microglobulin is homologous to the constant regions of the heavy and light chains of immunoglobulin, with a predominant structure of beta folded leaves. The protein is expressed ubiquitously in the cytoplasm and is involved in the treatment and presentation of antigens. Beta-2-microglobulin also plays a role in TCR signaling and downstream signaling in naive CD8+ cells. Beta 2-microglobulin is coded by the B2M gene on chromosome 15. A mutation in the beta-2-microglobulin gene has been demonstrated to induce hypercatabolic hypoproteinaemia. Beta 2-microglobulin concentrations can be used to evaluate renal function in renal transplant recipients. Beta-2-microglobulin can be used as a prognostic marker for VIH infection.
Sensitivity
Sensitivity of the dosage: 6 pg/ml.
Measurement range
Dose range: 15.6 to 1.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.